SCHEMBL1753889

SCHEMBL1753889

CC(=O)C(C)(C(C)=O)c1ccc(C(=O)Nc2ccccc2N)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 15/20 0.71
PTGS1 P23219 2/20 0.67
HDAC2 Q92769 9/20 0.64
HDAC3 O15379 8/20 0.64
MAPK1 P28482 1/20 0.64
NCOR2 Q9Y618 6/20 0.61
HDAC4 P56524 1/20 0.61
HDAC7 Q8WUI4 1/20 0.61
HDAC10 Q969S8 1/20 0.61
HDAC11 Q96DB2 1/20 0.61
HDAC8 Q9BY41 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
HDAC9 Q9UKV0 1/20 0.61
HDAC5 Q9UQL6 1/20 0.61
NPC1 O15118 1/20 0.51
ALDH1A1 P00352 1/20 0.51
GLA P06280 1/20 0.51
RAB9A P51151 1/20 0.51
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223727 0.86 PTGS1 (0.72) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL1753686 0.85 HDAC1 (0.69) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL12963543 0.85 PTGS1 (0.70) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL8401704 0.84 HDAC1 (0.89) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL1754084 0.83 HDAC1 (1.00) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL8349162 0.80 HDAC1 (0.70) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL14051543 0.80 HDAC1 (0.60) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL8242923 0.80 HDAC1 (0.74) HDAC1PTGS1HDAC2HDAC3MAPK1
SCHEMBL1060598 0.79 HDAC1 (0.79) HDAC1PTGS1HDAC2HDAC3MAPK1
Dinaline SCHEMBL29354254 0.79 HDAC1 (0.79) HDAC1PTGS1HDAC2HDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 HDAC1 6/4885PTGS1 1060/4885HDAC2 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.